{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:30:55Z","timestamp":1765233055371,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.leukres.2021.106538","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T17:29:48Z","timestamp":1613669388000},"page":"106538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada"],"prefix":"10.1016","volume":"103","author":[{"given":"Steven J.","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina S.","family":"Gerrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Hrynchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulwahab J.","family":"Al Tourah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8557-0325","authenticated-orcid":false,"given":"Gregory","family":"Dueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled M.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie H.","family":"Sehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia L.","family":"Toze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2021.106538_bib0005","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.leukres.2021.106538_bib0010","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/ejh.12468","article-title":"Survival for patients with chronic leukemias in the US and Britain: age-related disparities and changes in the early 21st century","volume":"94","author":"Pulte","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2021.106538_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0220864","article-title":"Racial\/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period","volume":"14","author":"Utuama","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2021.106538_bib0020","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1182\/blood-2007-12-129379","article-title":"Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century","volume":"111","author":"Brenner","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3324\/haematol.2009.007849","article-title":"Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica."},{"key":"10.1016\/j.leukres.2021.106538_bib0030","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1200\/JCO.2006.09.4508","article-title":"Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 Years of experience at the University of Texas M.D. Anderson Cancer Center","volume":"25","author":"Tsimberidou","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2021.106538_bib0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3324\/haematol.2013.086066","article-title":"Chronic lymphocytic leukemia in young (\u2264 55 years) patients: a comprehensive analysis of prognostic factors and outcomes","volume":"99","author":"Parikh","year":"2014","journal-title":"Haematologica."},{"key":"10.1016\/j.leukres.2021.106538_bib0040","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/10428194.2018.1509316","article-title":"Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey","volume":"60","author":"Eren","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2021.106538_bib0045","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1182\/blood.V78.6.1545.1545","article-title":"Presenting features and prognosis of chronic lymphocytic leukemia in younger adults","volume":"78","author":"Montserrat","year":"1991","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0609.1994.tb00648.x","article-title":"Comparison of younger versus older B\u2010cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases","volume":"52","author":"Molica","year":"1994","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.leukres.2021.106538_bib0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1182\/blood.V94.2.448","article-title":"Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases","volume":"94","author":"Mauro","year":"1999","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.leukres.2017.01.023","article-title":"Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada","volume":"55","author":"Huang","year":"2017","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2021.106538_bib0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/107327481502204s04","article-title":"Management of chronic lymphocytic leukemia in the elderly","volume":"22","author":"Barrientos","year":"2015","journal-title":"Cancer Control"},{"key":"10.1016\/j.leukres.2021.106538_bib0075","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0080","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0085","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0090","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/cncr.26474","article-title":"Hematologist\/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)\/small lymphocytic lymphoma (SLL)","volume":"118","author":"Shanafelt","year":"2012","journal-title":"Cancer."},{"key":"10.1016\/j.leukres.2021.106538_bib0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/cam4.559","article-title":"Comparison of outcome of patients with CLL who are referred or nonreferred to a specialized CLL clinic: a Canadian population-based study","volume":"5","author":"Beiggi","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.leukres.2021.106538_bib0100","doi-asserted-by":"crossref","first-page":"106335","DOI":"10.1016\/j.leukres.2020.106335","article-title":"Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada","volume":"91","author":"Huang","year":"2020","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2021.106538_bib0105","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cancergen.2014.08.006","article-title":"Population-based characterization of the genetic landscape of chronic lymphocytic leukemia patients referred for cytogenetic testing in British Columbia, Canada: the role of provincial laboratory standardization","volume":"207","author":"Gerrie","year":"2014","journal-title":"Cancer Genet."},{"year":"2012","series-title":"Chronic Lymphocytic Leukemia","key":"10.1016\/j.leukres.2021.106538_bib0110"},{"key":"10.1016\/j.leukres.2021.106538_bib0115","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1080\/10428194.2017.1387904","article-title":"Improved survival outcomes with the addition of rituximab to initial therapy for chronic lymphocytic leukemia: a comparative effectiveness analysis in the province of British Columbia, Canada","volume":"59","author":"Lee","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2021.106538_bib0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2004-03-0796","article-title":"Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0125","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.2010.31.1811","article-title":"Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712","volume":"29","author":"Woyach","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2021.106538_bib0130","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"376","author":"Hallek","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.leukres.2021.106538_bib0135","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1056\/NEJMoa1313984","article-title":"Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions","volume":"370","author":"Goede","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2021.106538_bib0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1182\/blood-2015-06-651125","article-title":"Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial","volume":"127","author":"Fischer","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.leukres.2021.106538_bib0145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2011.41.5646","article-title":"Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies","volume":"31","author":"Woyach","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.leukres.2021.106538_bib0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/bjh.14332","article-title":"Real-world clinical experience in the Connect\u00ae chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres","volume":"175","author":"Mato","year":"2016","journal-title":"Br. J. Haematol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212621000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:01:24Z","timestamp":1758934884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212621000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"alternative-id":["S0145212621000394"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106538","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2021.106538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106538"}}